STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
29.89
+0.81 (2.79%)
At close: May 29, 2026, 4:00 PM EDT
29.90
+0.01 (0.03%)
After-hours: May 29, 2026, 7:19 PM EDT
STAAR Surgical Company Revenue
STAAR Surgical Company had revenue of $93.52M in the quarter ending April 3, 2026, with 119.59% growth. This brings the company's revenue in the last twelve months to $290.38M, up 4.03% year-over-year. In the fiscal year ending January 2, 2026, STAAR Surgical Company had annual revenue of $239.44M, down -23.72%.
Revenue (ttm)
$290.38M
Revenue Growth
+4.03%
P/S Ratio
5.13
Revenue / Employee
$315,282
Employees
921
Market Cap
1.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 2, 2026 | 239.44M | -74.46M | -23.72% |
| Dec 27, 2024 | 313.90M | -8.51M | -2.64% |
| Dec 29, 2023 | 322.42M | 38.02M | 13.37% |
| Dec 30, 2022 | 284.39M | 53.92M | 23.40% |
| Dec 31, 2021 | 230.47M | 67.01M | 41.00% |
| Jan 1, 2021 | 163.46M | 13.28M | 8.84% |
| Jan 3, 2020 | 150.19M | 26.23M | 21.16% |
| Dec 28, 2018 | 123.95M | 33.34M | 36.80% |
| Dec 29, 2017 | 90.61M | 8.18M | 9.92% |
| Dec 30, 2016 | 82.43M | 5.31M | 6.88% |
| Jan 1, 2016 | 77.12M | 2.14M | 2.85% |
| Jan 2, 2015 | 74.99M | 2.77M | 3.84% |
| Jan 3, 2014 | 72.22M | 8.43M | 13.22% |
| Dec 28, 2012 | 63.78M | 1.02M | 1.62% |
| Dec 31, 2011 | 62.77M | 7.81M | 14.21% |
| Dec 31, 2010 | 54.96M | 3.90M | 7.63% |
| Jan 1, 2010 | 51.06M | 1.29M | 2.59% |
| Jan 2, 2009 | 49.77M | -9.59M | -16.16% |
| Dec 28, 2007 | 59.36M | 2.41M | 4.24% |
| Dec 29, 2006 | 56.95M | 5.65M | 11.01% |
| Dec 30, 2005 | 51.30M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTSPLY SIRONA | 3.68B |
| Warby Parker | 890.57M |
| Azenta | 596.48M |
| AtriCure | 552.16M |
| LeMaitre Vascular | 256.28M |
| BioLife Solutions | 101.66M |
| Alamar Biosciences | 87.16M |
| Kestra Medical Technologies | 83.72M |
STAA News
- 2 days ago - STAAR Surgical Company Transcript: Status update - Transcripts
- 3 days ago - STAAR Surgical Company Transcript: Stifel 2026 Virtual Ophthalmology Forum - Transcripts
- 8 days ago - STAAR Surgical Announces Participation in Upcoming Investor Conferences - Business Wire
- 15 days ago - Staar Surgical upgraded to Outperform from Neutral at Wedbush - TheFly
- 15 days ago - Staar Surgical price target raised to $32 from $27 at Canaccord - TheFly
- 16 days ago - Staar Surgical price target raised to $27 from $22 at Mizuho - TheFly
- 16 days ago - Wedbush upgrades Staar Surgical to Outperform on China rebound - TheFly
- 16 days ago - Staar Surgical price target raised to $31 from $18 at Stifel - TheFly